Drugs Made in America AcquisDMAAU
13F holders, Q1 2025 (March 31)15holders
1famous investor
$10.15avg. 13F price*
At the end of Q1 2025, 15 institutions reported holding Drugs Made in America Acquis (DMAAU) in their 13F filings. The largest holders were Heights Capital Management, Inc. ($6.6M), Boothbay Fund Management, LLC ($6.1M) and Westchester Capital Management, LLC ($5.1M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Drugs Made in America Acquis
- CUSIP
- G2847J120
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $33.4M |
| Exits | 0 | $0 |
Ownership 15 holders
| Heights Capital Management, Inc. | 3.37% | New | 650,000 | $6.6M |
| Boothbay Fund Management, LLC | 0.22% | New | 603,750 | $6.1M |
| Westchester Capital Management, LLC | 0.30% | New | 500,000 | $5.1M |
| Rivernorth Capital Management, LLC | 0.23% | New | 420,498 | $4.3M |
| Context Capital Management, LLC | 3.41% | New | 250,000 | $2.5M |
| Schonfeld Strategic Advisors LLC | 0.02% | New | 234,831 | $2.4M |
| Bulldog Investors, LLP | 0.36% | New | 130,264 | $1.3M |
| Wolverine Asset Management LLC | 0.10% | New | 130,000 | $1.3M |
| Parallax Volatility Advisers, L.P. | 0.04% | New | 100,000 | $1.0M |
| Verition Fund Management LLC | 0.01% | New | 100,000 | $1.0M |
| Murchinson Ltd. | 0.16% | New | 90,000 | $915K |
| Tuttle Capital Management, LLC | 1.79% | New | 40,000 | $407K |
| UBS Group AG | 0.00% | New | 18,278 | $186K |
| Citadel Advisors | 0.00% | New | 15,753 | $159K |
| Clear Street LLC | 0.00% | New | 5,849 | $59K |
"% of holder's portfolio" is DMAAU's weight in each manager's 13F, not the share of Drugs Made in America Acquis the manager owns.